bluebird bio Inc. (NASDAQ: BLUE)
$1.39
+0.0650 ( +4.92% ) 4.2M
bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.
Market Data
Open
$1.39
Previous close
$1.32
Volume
4.2M
Market cap
$182.68M
Day range
$1.31 - $1.40
52 week range
$0.85 - $5.53
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 12 | Dec 14, 2023 |
8-k | 8K-related | 30 | Dec 11, 2023 |
4 | Insider transactions | 2 | Dec 08, 2023 |
8-k | 8K-related | 14 | Nov 07, 2023 |
10-q | Quarterly Reports | 70 | Nov 07, 2023 |
4 | Insider transactions | 2 | Nov 03, 2023 |
4 | Insider transactions | 2 | Nov 03, 2023 |
8-k | 8K-related | 13 | Oct 30, 2023 |
8-k | 8K-related | 12 | Sep 27, 2023 |
4 | Insider transactions | 2 | Sep 06, 2023 |